Hindustan Unilever informed that the National Company Law Tribunal (NCLT) Chandigarh has approved a scheme of amalgamation between GlaxoSmithKline Consumer Healthcare and the company.
The FMCG major had announced on 6 November 2019 that the scheme of amalgamation was previously approved by the National Company Law Tribunal, Mumbai Bench vide it's order dated 24 September 2019.It added that the effective date of the scheme will be communicated upon being finalized by the Transferor Company (GlaxoSmithKline Consumer Healthcare) and the Company (HUL), in accordance with the procedure specified under the Scheme approved by the Mumbai NCL T and Chandigarh NCLT.
Shares of Hindustan Unilever added 0.21% to Rs 2245.60 while those of Glaxosmithkline Consumer Healthcare gained 1.11% to Rs 9745.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
